基于二的金属复合体在癌症中的治疗潜力,其特点是11组元素
María Gil-Moles1,2, M Concepción Gimeno1
1Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain.
ChemMedChem
|February 8, 2024
概括
与第11组金属的特皮里丁复合物显示出希望作为癌症治疗的金属药物. 这些化合物表现出强大的抗癌活性和选择性,主要是通过DNA相互作用和亡诱导.
科学领域:
- 药用化学 医学化学
- 无机化学 无机化学
- 癌症生物学 癌症生物学
背景情况:
- 基于二的金属复合物正在成为癌症治疗中的重要金属药物.
- 铜 (II) 复合物得到了广泛的研究,而银和金复合物仍未得到充分的探索.
- 这些金属药物对癌细胞具有细胞毒性,对非瘤细胞具有选择性.
研究的目的:
- 为了回顾目前的抗癌特皮里丁基11组金属复合物的现状.
- 突出它们在癌症治疗中的作用机制.
- 确定未来研究和探索新生物目标的领域.
主要方法:
- 审查现有的关于铜,白银和黄金的基于terpyridine的复合物的文献.
- 对详细说明它们对各种癌症细胞系的细胞毒性作用的研究进行分析.
- 检查报告的作用机制,包括DNA相互作用和亡诱导.
主要成果:
- 具有多种连接体的铜 (II) 复合体是最常见的,并表现出核酶活性,通过活性氧物种 (ROS) 生成诱导亡.
- 银复合体表现出作为DNA间剂的潜力,导致水解裂变.
- 黄金 (III) 化合物干扰DNA,诱导亡,并破坏线粒体膜,而黄金 (I) 复合物不太稳定.
结论:
- 基于特皮里丁的11组金属复合物是具有有前途的选择性的强效抗癌剂.
- DNA相互作用和亡诱导是关键机制,由连接体设计调节.
- 进一步的研究至关重要,以阐明完整的机制,并探索这些金属药物的新生物点.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
291
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
291
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163


